PersonalizeDx, a Rosetta Genomics Company, is a CAP accredited, CLIA certified laboratory that serves the testing needs of Pathologists, Urologists, Oncologists, and other reference laboratories.

Our area of particular focus is in the early detection of genomic changes, through Fluorescence in situ Hybridization (FISH) technology, that may detect cancer, measure the potential aggressiveness of the disease, as well as identify patients most likely to respond to targeted therapies. Through our Rosetta Genomics laboratory (www.rosettagenomics.com), we also offer the microRNA-based Rosetta Cancer Origin Test, as well as other proprietary test offerings in Lung and Kidney Cancers.

We offer flexible testing solutions that are tailored to each client’s needs, with a particular focus in Prostate, Bladder, Lung and Breast Cancers.